Literature DB >> 26362847

Association of periodontitis with persistent, pro-atherogenic antibody responses.

Kåre Buhlin1,2, Jacob Holmer1, Anders Gustafsson1, Sohvi Hörkkö3, Alan Graham Pockley4, Anders Johansson5, Susanna Paju2, Björn Klinge1,6, Pirkko J Pussinen2.   

Abstract

AIM: To study antibody responses associated with molecular mimicry in periodontitis. MATERIAL &
METHODS: Fifty-four periodontitis cases (mean age 54.0 years) and 44 controls (53.6 years) were examined, after which cases received periodontal treatment. Established immunoassays were used to analyse levels of antibodies against two pathogens, Aggregatibacter actinomycetemcomitans (Aa) and Porphyromonas gingivalis (Pg), heat shock proteins (Hsp), Hsp60, Hsp65, and Hsp70, and epitopes of oxidized low-density lipoprotein (oxLDL) (CuOx-LDL and MDA-LDL) in plasma samples that were collected at baseline and after 3 (n = 48) and 6 (n = 30) months.
RESULTS: When age, sex, smoking habit, and the number of teeth were considered in multivariate logistic regressions, Aa and Pg IgG, Hsp65-IgA, CuOx-LDL-IgG and -IgM, and MDA-LDL-IgG antibody levels were associated with periodontitis, whereas Hsp60-IgG2 antibody levels were inversely associated. The Aa antibody levels significantly correlated with the levels of IgA antibodies to Hsp65 and Hsp70, and both OxLDL IgA antibody levels. The levels of antibodies to Pg correlated with IgG antibodies to Hsp60, Hsp70, and both oxLDL antibody epitopes. None of the antibody levels changed significantly after treatment.
CONCLUSIONS: Periodontitis is associated with persistently high levels of circulating antibodies that are reactive with pathogen- and host-derived antigens.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  antibody; heat shock proteins; lipoproteins; periodontal disease; periodontal treatment

Mesh:

Substances:

Year:  2015        PMID: 26362847     DOI: 10.1111/jcpe.12456

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  7 in total

1.  Biofilm formation - what we can learn from recent developments.

Authors:  T Bjarnsholt; K Buhlin; Y F Dufrêne; M Gomelsky; A Moroni; M Ramstedt; K P Rumbaugh; T Schulte; L Sun; B Åkerlund; U Römling
Journal:  J Intern Med       Date:  2018-07-09       Impact factor: 8.989

2.  Characterization of a natural mouse monoclonal antibody recognizing epitopes shared by oxidized low-density lipoprotein and chaperonin 60 of Aggregatibacter actinomycetemcomitans.

Authors:  Chunguang Wang; Jari Kankaanpää; Outi Kummu; S Pauliina Turunen; Ramin Akhi; Ulrich Bergmann; Pirkko Pussinen; Anne M Remes; Sohvi Hörkkö
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

Review 3.  Relación entre la disbiosis de la microbiota oral y la enfermedad cardiovascular aterosclerótica.

Authors:  Paulina Hernández-Ruiz; Héctor González-Pacheco; Luis M Amezcua-Guerra; Ma Magdalena Aguirre-García
Journal:  Arch Cardiol Mex       Date:  2022

4.  Exposure to Aggregatibacter actinomycetemcomitans before Symptom Onset and the Risk of Evolving to Rheumatoid Arthritis.

Authors:  Eduardo Gomez-Bañuelos; Linda Johansson; Maximilian F Konig; Anders Lundquist; Merlin Paz; Kåre Buhlin; Anders Johansson; Solbritt Rantapää-Dahlqvist; Felipe Andrade
Journal:  J Clin Med       Date:  2020-06-18       Impact factor: 4.241

Review 5.  Oral Dysbiosis and Autoimmunity: From Local Periodontal Responses to an Imbalanced Systemic Immunity. A Review.

Authors:  Lina J Suárez; Hernan Garzón; Silie Arboleda; Adriana Rodríguez
Journal:  Front Immunol       Date:  2020-12-08       Impact factor: 7.561

Review 6.  Oxidative Stress in the Local and Systemic Events of Apical Periodontitis.

Authors:  Patricia Hernández-Ríos; Pirkko J Pussinen; Rolando Vernal; Marcela Hernández
Journal:  Front Physiol       Date:  2017-11-01       Impact factor: 4.566

Review 7.  The Functions and Therapeutic Potential of Heat Shock Proteins in Inflammatory Bowel Disease-An Update.

Authors:  Abdullah Hoter; Hassan Y Naim
Journal:  Int J Mol Sci       Date:  2019-10-26       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.